Drug: metoclopramide Quarter: 2016Q3
Total Records: 411 Number of Pages: 21
| DRUGNAME | PT | EventCount |
|---|---|---|
| METOCLOPRAMIDE. | Dysarthria | 1 |
| METOCLOPRAMIDE. | Dysphonia | 1 |
| METOCLOPRAMIDE. | Dyspnoea exertional | 1 |
| METOCLOPRAMIDE. | Encephalopathy | 1 |
| METOCLOPRAMIDE. | Erectile dysfunction | 1 |
| METOCLOPRAMIDE. | Euphoric mood | 1 |
| METOCLOPRAMIDE. | Exposure during breast feeding | 1 |
| METOCLOPRAMIDE. | Extrapyramidal disorder | 1 |
| METOCLOPRAMIDE. | Fear | 1 |
| METOCLOPRAMIDE. | Feeding disorder | 1 |
| METOCLOPRAMIDE. | Feeling cold | 1 |
| METOCLOPRAMIDE. | Feeling hot | 1 |
| METOCLOPRAMIDE. | Flushing | 1 |
| METOCLOPRAMIDE. | Fracture reduction | 1 |
| METOCLOPRAMIDE. | Gamma-glutamyltransferase increased | 1 |
| METOCLOPRAMIDE. | Gastrointestinal viral infection | 1 |
| METOCLOPRAMIDE. | General physical health deterioration | 1 |
| METOCLOPRAMIDE. | Haemolytic anaemia | 1 |
| METOCLOPRAMIDE. | Hallucination | 1 |
| METOCLOPRAMIDE. | Hepatic steatosis | 1 |
Total Records: 411 Number of Pages: 21